Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | ESR1 | P03372 | 2/20 | 0.41 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.41 |
| ▸ | TACR2 | P21452 | 2/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | SHBG | P04278 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.41 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.41 |
| ▸ | HTR2C | P28335 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13564086 | 0.98 | CYP1A2 (0.45) | CYP1A2CYP2D6CYP2C19ALOX15ESR1 | |
| SCHEMBL16981555 | 0.95 | CYP1A2 (0.45) | CYP1A2CYP2D6CYP2C19ALOX15ESR1 | |
| SCHEMBL16981552 | 0.95 | CYP1A2 (0.45) | CYP1A2CYP2D6CYP2C19ALOX15ESR1 | |
| SCHEMBL13564000 | 0.95 | CYP1A2 (0.47) | CYP1A2CYP2D6CYP2C19ALOX15ALDH1A1 | |
| SCHEMBL5337478 | 0.90 | CYP1A2 (0.56) | CYP1A2CYP2D6CYP2C19ALOX15ESR1 | |
| SCHEMBL13563986 | 0.88 | CNR1 (0.42) | ESR1ADRA2AADORA3TACR2SLC6A2 | |
| SCHEMBL13563995 | 0.88 | RAB9A (0.45) | CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL13564080 | 0.87 | PTGS2 (0.44) | ESR1ADRA2AADORA3TACR2SLC6A2 | |
| SCHEMBL13562051 | 0.87 | CYP1A2 (0.43) | CYP1A2CYP2D6CYP2C19RORARORC | |
| SCHEMBL16806152 | 0.86 | CYP1A2 (0.53) | CYP1A2CYP2D6CYP2C19ALOX15ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8946688-B2 | Polycyclic ring-fused compound and organic thin film transistor utilizing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2015-02-03 | — | — | US | disclosed |
| US-20120273770-A1 | POLYCYCLIC RING-FUSED COMPOUND AND ORGANIC THIN FILM TRANSISTOR UTILIZING SAME | IDEMITSU KOSAN CO., LTD. | 2012-11-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120273770-A1 | POLYCYCLIC RING-FUSED COMPOUND AND ORGANIC THIN FILM TRANSISTOR UTILIZING SAME | TCF4, JUN, CTCF | CYP1A2 341/4885CYP2D6 1190/4885CYP2C19 237/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.